Sydney Shall
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Physiology top 0.5%
- Calcium signaling and nucleotide metabolism
Papers in
-
- DNA Repair Mechanisms 27
- Biochemical and Molecular Research 11
- Cancer therapeutics and mechanisms 11
- Oncology 59
- PARP inhibition in cancer therapy 53
- Co-authors
- Douglas A. Gray (3 shared papers)Barbara W. Durkacz (4 shared papers)Olusesan Omidiji (1 shared paper)Gilbert de Murcia (1 shared paper)Farzin Farzaneh (14 shared papers)C. J. Skidmore (7 shared papers)Kinsey Maundrell (3 shared papers)David Brill (2 shared papers)
- Journals
- Biochemical Society Transactions (14 papers)European Journal of Biochemistry (9 papers)Nature (8 papers)FEBS Letters (8 papers)Nucleic Acids Research (4 papers)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Sydney Shall
131 papers receiving 5.2k citations
Sydney Shall's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 2.9k
- Physiology 527
- Aging 134
- Molecular Biology 3.9k
- Immunology 868
Countries citing papers authored by Sydney Shall
This map shows the geographic impact of Sydney Shall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sydney Shall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sydney Shall more than expected).
Fields of papers citing papers by Sydney Shall
This network shows the impact of papers produced by Sydney Shall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sydney Shall. The network helps show where Sydney Shall may publish in the future.
Co-authors
The 25 scholars most cited alongside Sydney Shall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | (ADP-ribose)n participates in DNA excision repair Hit paper breakdown → | 1980 | 919 |
| 2 | 2000 | 432 | |
| 3 | 1982 | 316 | |
| 4 | 1982 | 293 | |
| 5 | 1979 | 236 | |
| 6 | 1980 | 164 | |
| 7 | 1993 | 127 | |
| 8 | 1988 | 123 | |
| 9 | From DNA damage and stress signalling to cell death : poly-ADP-ribosylation reactions | 2000 | 114 |
| 10 | 1978 | 100 | |
| 11 | 1985 | 98 | |
| 12 | 1995 | 96 | |
| 13 | 1980 | 95 | |
| 14 | 1974 | 94 | |
| 15 | 1978 | 89 | |
| 16 | 1971 | 86 | |
| 17 | 1975 | 74 | |
| 18 | 1994 | 67 | |
| 19 | 1985 | 66 | |
| 20 | 2009 | 64 |
About Sydney Shall
Sydney Shall is a scholar working on Molecular Biology, Oncology, Immunology, Biomedical Engineering and Physiology, having authored 132 papers that have together received 5.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (53 papers), DNA Repair Mechanisms (27 papers), Toxin Mechanisms and Immunotoxins (18 papers), Calcium signaling and nucleotide metabolism (15 papers), Biochemical and Molecular Research (11 papers), Cancer therapeutics and mechanisms (11 papers), Slime Mold and Myxomycetes Research (8 papers) and Telomeres, Telomerase, and Senescence (8 papers). The work is most often cited by research in Oncology (2.9k citations), Physiology (527 citations), Aging (134 citations), Molecular Biology (3.9k citations) and Immunology (868 citations). Sydney Shall has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Douglas A. Gray, Barbara W. Durkacz, Olusesan Omidiji, Gilbert de Murcia, Farzin Farzaneh, C. J. Skidmore, Kinsey Maundrell, David Brill, Rosalind J. Zalin and WILLIAM J. D. WHISH. Their work appears in journals such as Biochemical Society Transactions, European Journal of Biochemistry, Nature, FEBS Letters and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.